TURKLAB A.S.

Name

TURKLAB A.S.

Legal name

Türklab A.Ş.

Website

https://turklab.com.tr

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

In Vitro Diagnostic Test Kits

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Rapid Antigen/Antibody Lateral Flow Tests (General Platform Category) (HLAHAOAH)

akta.pro secondary industry

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

Keywords

• Rapid diagnostic tests
• Immunochromatographic assays
• Lateral flow diagnostics
• In vitro diagnostics
• Medical test kits

Headquarters

HQ city

İzmir

HQ country

Türkiye

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Rapid Diagnostic Test Kit Sales: TURKLAB generates revenue through the manufacture and sale of rapid diagnostic test kits for detection of infectious diseases, cardiac markers, tumor markers, fertility/hormone tests, and blood grouping applications.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

TURKLAB A.S. manufactures and sells rapid immunochromatographic (lateral flow) diagnostic test kits for human in vitro diagnostics, covering infectious diseases (HIV, HCV, Hepatitis B, H. pylori, Rotavirus, Adenovirus, Strep A, Influenza, TB, Procalcitonin), COVID-19 antigen/antibody tests, sexually transmitted disease tests, tropical disease tests (Malaria, Dengue), tumor markers, fertility/pregnancy tests, cardiac markers, and blood grouping products, plus vacuum blood collection tubes. Its kits use proprietary gold nano-particle, silver nano-particle, and quantum dot detection technologies to deliver qualitative results in approximately 10–15 minutes at the point of care, without requiring centralized laboratory infrastructure, and are sold to healthcare providers, laboratories, hospitals, and public health authorities worldwide.

Product overview

TURKLAB A.S. is a Turkish medical diagnostics company specializing in rapid immunochromatographic test kits for human in vitro diagnostics. The product portfolio includes infectious disease tests (HIV, HCV, Hepatitis B, H.pylori, Rotavirus, Adenovirus, Strep A, Influenza, Tuberculosis), COVID-19 test kits (antigen and antibody), sexually transmitted disease tests (Syphilis), tropical disease tests (Malaria, Dengue), tumor marker tests (fecal occult blood, Calprotectin), fertility tests (hCG pregnancy), cardiac marker tests (Troponin I, Myoglobin, CK-MB), and blood grouping products (gel cards, cells, diluents). The company also produces blood collection tubes and develops advanced detection technologies including gold nanoparticles, silver nanoparticles, and quantum dots. Tests are designed for use with various sample types including whole blood, serum, plasma, and stool samples, with read times typically ranging from 10-15 minutes.

Differentiator

Problem solved

Functional benefit

Brands

• TURKLAB: Rapid diagnostic test kits for professional use including infection diseases, COVID-19, tropical diseases, cardiac markers, fertility, and blood grouping

Products and services

• Anti-HIV 1/2 Testi Rapid immunochromatographic test for qualitative detection of antibodies to HIV-1 and HIV-2 in human whole blood, serum, or plasma; for professional clinical laboratory use.
• Anti-HCV Testi Rapid immunochromatographic test for qualitative detection of antibodies to Hepatitis C virus in human whole blood, serum, or plasma; for professional clinical laboratory use.
• HBsAg Testi Rapid immunochromatographic test for qualitative detection of Hepatitis B surface antigen in human serum, plasma, and whole blood samples; sensitivity 99.89%; for professional clinical laboratory use.
• Anti-HBs Testi Rapid immunochromatographic test for qualitative detection of antibodies against Hepatitis B surface antigen in human serum, plasma, and whole blood; 100% sensitivity and 100% specificity; for professional clinical laboratory use.
• H.pylori Ag Testi Rapid immunochromatographic test for qualitative detection of H. pylori antigens in human stool samples; 99.9% sensitivity and 99.9% specificity with 10-minute read time; for professional clinical laboratory use.
• H.pylori Ab Testi Rapid immunochromatographic test for qualitative detection of antibodies against H. pylori in human whole blood, serum, or plasma; 98.7% sensitivity and 93.2% specificity; for professional clinical laboratory use.
• Rotavirüs Testi Rapid immunochromatographic test for detection of Rotavirus antigens in stool samples; for professional clinical laboratory use.
• Adenovirüs Testi Rapid immunochromatographic test for detection of Adenovirus antigens; for professional clinical laboratory use.
• Rotavirüs Adenovirüs Testi Rapid immunochromatographic combination test for simultaneous detection of Rotavirus and Adenovirus antigens; for professional clinical laboratory use.
• Strep A Testi Rapid immunochromatographic test for detection of Group A Streptococcus antigens from throat swab; for professional clinical laboratory use and antibiotic stewardship.
• İnfulenza (Grip) A/B Testi Rapid immunochromatographic test for differential detection of Influenza A and Influenza B virus antigens; for professional clinical laboratory use.
• Tüberküloz (TB) Testi Rapid immunochromatographic test for detection of Tuberculosis antigens; for professional clinical laboratory use.
• Procalcitonin (PCT) Test Rapid test for quantitative detection of Procalcitonin, a biomarker used to assess severity of bacterial infection and sepsis; for professional clinical laboratory use.
• COVID-19 Ag Test Rapid antigen test for professional use for detection of SARS-CoV-2 virus; approved by BfArM (Germany) and received HSC (Singapore) approval.
• SARS-CoV-2 IgM/IgG Ab Testi Rapid immunochromatographic test for detection of IgM and IgG antibodies against SARS-CoV-2 virus; for professional clinical laboratory use.
• Anti-Sifilis Testi Rapid immunochromatographic test for detection of antibodies against syphilis (Treponema pallidum); for professional clinical laboratory use.
• Malarya pf/pan Testi Rapid immunochromatographic test for detection of Plasmodium falciparum (pf) and Plasmodium vivax/ovale/malariae/knowlesi (pan) malaria antigens in whole blood; for professional clinical laboratory use.
• Dengue IgG/IgM Testi Rapid immunochromatographic test for detection of IgG and IgM antibodies against Dengue virus; for professional clinical laboratory use.
• Dengue NS1 Testi Rapid immunochromatographic test for detection of Dengue virus NS1 antigen; for professional clinical laboratory use.
• Dengue NS1, IgG/IgM Testi Rapid combination immunochromatographic test for simultaneous detection of Dengue NS1 antigen and IgG/IgM antibodies; for professional clinical laboratory use.
• Gaitada Gizli Kan Testi Rapid immunochromatographic test for qualitative detection of occult blood in stool samples as a tumor marker screen; for professional clinical laboratory use.
• Gaitada Gizli Kan Testi (Guiac Method) Rapid test kit for detection of fecal occult blood using the Guiac chemical method; for professional clinical laboratory use.
• Calprotectin Test Rapid test for quantitative detection of Calprotectin, a marker for intestinal inflammation; for professional clinical laboratory use.
• hCG Gebelik Kaset Testi Rapid immunochromatographic test for qualitative detection of human Chorionic Gonadotropin (hCG) in urine or serum for pregnancy detection; first TURKLAB product to receive CE mark; FDA-approved for OTC and personal use.
• Troponin I Testi Rapid immunochromatographic test for detection of Troponin I, a cardiac biomarker for myocardial infarction; for professional clinical laboratory use.
• Miyoglobin / CK-MB / Troponin I Testi Rapid combination immunochromatographic test for simultaneous detection of Myoglobin, CK-MB, and Troponin I cardiac biomarkers; for professional clinical laboratory use.
• Jel Kartları (Gel Cards) Gel cards used for blood grouping and cross-matching tests; for professional blood bank and clinical laboratory use.
• Hücreler (Blood Grouping Reagent Cells) Blood grouping reagent cells used for serological blood typing; for professional blood bank and clinical laboratory use.
• Dilüent ve Solusyonlar (Diluents and Solutions) Diluents and solutions used in blood grouping and immunohematology testing workflows; for professional blood bank and clinical laboratory use.
• Kan Toplama Tüpleri (Blood Collection Tubes) Vacuum blood collection tubes in multiple variants (EDTA, heparin, gel, and various sizes) for sample collection; supplied to specialized laboratories and hospitals.

Quantifiable outcome

• H.pylori Ag test: 99.9% sensitivity and 99.9% specificity
• +4 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Bio-Rad Laboratories: US-based clinical diagnostics and life science company with rapid test and immunoassay products used in hospitals and reference labs. Overlaps with TURKLAB in infectious disease screening but operates at significantly greater scale and scope.
• Abbott Diagnostics: Global IVD incumbent with extensive rapid test portfolio (Binax COVID/Flu, Determine HIV, pregnancy, cardiac). Competes with TURKLAB in many of the same tender categories, but as part of a much larger diversified diagnostics franchise.

Emerging players

• Wondfo Biotech: China-based manufacturer of rapid diagnostic test kits (infectious disease, fertility, drugs of abuse) with strong export presence into emerging markets. Comparable to TURKLAB in lateral flow product focus and global tender-driven GTM, though larger scale and broader portfolio.
• Hangzhou AllTest Biotech: China-based rapid diagnostic test manufacturer with broad infectious disease, fertility, cardiac, and drugs-of-abuse lateral flow products sold globally. Comparable in lateral flow technology and OEM/distributor-driven GTM, though generally a lower-cost competitor.

Direct peers

• Trinity Biotech: Ireland-based specialty diagnostics company with a rapid test portfolio (HIV, hepatitis, syphilis) sold through tenders and public health channels. Comparable to TURKLAB in lateral flow focus, reliance on regulatory approvals, and small-mid cap manufacturer profile.
• SD Biosensor: Korean IVD company focused on rapid diagnostic test kits (COVID-19, HIV, influenza, dengue, pregnancy) for global public health and clinical markets. Closely comparable to TURKLAB in product mix (lateral flow rapid tests), B2B tender-based GTM, and reliance on global health agency qualifications.
• GenBody: Korean in-vitro diagnostics company producing rapid antigen/antibody test kits (COVID-19, infectious disease, cardiac markers) for professional and at-home use. Closely comparable to TURKLAB in lateral flow technology, regulatory strategy (CE/FDA), and export-oriented GTM.
• Acon Laboratories: US-headquartered rapid diagnostics manufacturer (Flowflex COVID-19, pregnancy, infectious disease, cardiac, drugs-of-abuse tests) selling through tenders and distributors worldwide. Highly comparable mid-sized lateral flow peer to TURKLAB in both product portfolio and channel strategy.
• Meril Diagnostics: Indian IVD subsidiary of Meril Group manufacturing rapid diagnostic test kits (HIV, hepatitis, dengue, malaria, pregnancy, cardiac). Comparable emerging-market lateral flow manufacturer with similar GTM targeting public health tenders and emerging markets.
• J. Mitra & Co. Indian IVD company specializing in rapid diagnostic test kits for infectious disease, blood grouping, and pregnancy. Comparable to TURKLAB as a mid-sized lateral flow manufacturer focused on emerging market public health buyers and CE/FDA/NABL certifications.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/turklab-medical-devices

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TURKLAB A.S.